Found: 10
Select item for more details and to access through your institution.
HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab) Administered to Healthy Male Subjects.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 393, doi. 10.1007/s40259-022-00534-w
- By:
- Publication type:
- Article
Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 359, doi. 10.1007/s40259-022-00533-x
- By:
- Publication type:
- Article
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 337, doi. 10.1007/s40259-022-00532-y
- By:
- Publication type:
- Article
Dengue Vaccines: An Update.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 325, doi. 10.1007/s40259-022-00531-z
- By:
- Publication type:
- Article
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 341, doi. 10.1007/s40259-022-00530-0
- By:
- Publication type:
- Article
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 231, doi. 10.1007/s40259-022-00529-7
- By:
- Publication type:
- Article
Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 381, doi. 10.1007/s40259-022-00528-8
- By:
- Publication type:
- Article
Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 421, doi. 10.1007/s40259-022-00526-w
- By:
- Publication type:
- Article
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 373, doi. 10.1007/s40259-022-00525-x
- By:
- Publication type:
- Article
Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 411, doi. 10.1007/s40259-022-00524-y
- By:
- Publication type:
- Article